Search Results
You are looking at 1 - 4 of 4 items for
- Author: H Matsumoto x
- Refine by access: All content x
Search for other papers by H. ENDO in
Google Scholar
PubMed
Search for other papers by K. KOTOH in
Google Scholar
PubMed
Search for other papers by K. MATSUMOTO in
Google Scholar
PubMed
Search for other papers by K. OKANO in
Google Scholar
PubMed
Progestin released from the ovaries of pregnant rabbits consists of 20α-hydroxypregn-4-en-3-one (20α-dihydroprogesterone) and progesterone (Hafez, Tsutsumi & Kahn, 1965; Okano, Matsumoto, Kotoh, Endo & Seki, 1966). Because corpora lutea (c.l.), follicles and interstitial tissue are normally present in the ovaries of pregnant rabbits, it has been difficult to determine whether interstitial tissue and c.l. both secrete both steroids (Dorrington & Kilpatrick, 1965), or whether, as is frequently assumed, 20α-dihydroprogesterone comes predominantly from interstitial tissue and progesterone from c.l. (Hilliard, Archibald & Sawyer, 1963; Hilliard, Spies, Lucas & Sawyer, 1968). Recently it has been shown that progesterone comes from c.l. and not from interstitial tissue by experiments using unilaterally X-irradiated ovaries of pregnant rabbits: these contained either c.l. and interstitial tissue or interstitial tissue alone (Keyes & Nalbandov, 1968). In this paper, further evidence of the site of progesterone secretion is reported from experiments using normal ovaries of pregnant rabbits.
White
Search for other papers by T Matsumoto in
Google Scholar
PubMed
Search for other papers by T Tsurumoto in
Google Scholar
PubMed
Search for other papers by MB Goldring in
Google Scholar
PubMed
Search for other papers by H Shindo in
Google Scholar
PubMed
Insulin-like growth factor-I (IGF-I) is an important anabolic factor for cartilage tissue and its action is, in part, regulated by IGF-binding proteins (IGFBPs). The object of this study was to investigate the effects of IGFBPs on IGF-I action and on binding of IGF-I to cells using a reproducible immortalized human chondrocyte culture model. Treatment of the C-28/I2 cells with IGF-I or des(1-3)IGF-I in serum-free medium stimulated cell proliferation in a dose-dependent manner. However, the effect of des(1-3)IGF-I was more potent, thereby suggesting that endogenously produced IGFBPs inhibited IGF action. The stimulatory effect of IGF-I was inhibited significantly by addition of IGFBP-3 but enhanced slightly by IGFBP-5. However, neither IGFBP-3 nor IGFBP-5 had an effect on basal cell growth. Binding of (125)I-labeled IGF-I to the cells was displaced by both IGFBP-3 and IGFBP-5, although higher concentrations of unlabeled IGFBP-5 were required to displace IGF-I to the same extent as IGFBP-3. Treatment of the cells with IGF-I increased the levels of IGFBP-5 protein measured by Western ligand blotting, and stimulated a corresponding increase in IGFBP-5 mRNA while increasing type II collagen mRNA. Our findings indicate that the balance between IGFBP-3 and IGFBP-5 influences IGF receptor binding and its action on chondrocyte proliferation, and may thereby modulate cartilage metabolism.
Search for other papers by H Otsubo in
Google Scholar
PubMed
Search for other papers by S Hyodo in
Google Scholar
PubMed
Search for other papers by H Hashimoto in
Google Scholar
PubMed
Search for other papers by M Kawasaki in
Google Scholar
PubMed
Search for other papers by H Suzuki in
Google Scholar
PubMed
Search for other papers by T Saito in
Google Scholar
PubMed
Search for other papers by T Ohbuchi in
Google Scholar
PubMed
Search for other papers by T Yokoyama in
Google Scholar
PubMed
Search for other papers by H Fujihara in
Google Scholar
PubMed
Search for other papers by T Matsumoto in
Google Scholar
PubMed
Search for other papers by Y Takei in
Google Scholar
PubMed
Search for other papers by Y Ueta in
Google Scholar
PubMed
Search for other papers by T Yoshimoto in
Google Scholar
PubMed
Search for other papers by M Naruse in
Google Scholar
PubMed
Search for other papers by Z Zeng in
Google Scholar
PubMed
Search for other papers by T Nishikawa in
Google Scholar
PubMed
Search for other papers by T Kasajima in
Google Scholar
PubMed
Search for other papers by H Toma in
Google Scholar
PubMed
Search for other papers by S Yamamori in
Google Scholar
PubMed
Search for other papers by H Matsumoto in
Google Scholar
PubMed
Search for other papers by A Tanabe in
Google Scholar
PubMed
Search for other papers by K Naruse in
Google Scholar
PubMed
Search for other papers by H Demura in
Google Scholar
PubMed
To explore the clinical significance of p53 in the pathogenesis of adrenal neoplasms, we investigated the incidence of p53 gene mutations in functioning human adrenal tumours using the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) technique to screen p53 exons 4 to 9. We examined 29 adrenocortical adenomas (primary aldosteronism, n=17; Cushing's syndrome, n=12, all benign), and 33 phaeochromocytomas (benign solitary, n=18; benign multiple, n=5; malignant, n=10) in Japanese and Chinese patients. PCR-SSCP did not show any abnormal band-shifts in any of the adrenocortical adenoma and benign solitary phaeochromocytoma tissues. In contrast, six phaeochromocytoma tissues (two cases benign multiple, four cases malignant) showed PCR-SSCP band-shifts. Subsequent DNA sequencing analysis of the shifted bands revealed six cases with nine mutations or intronic sequence alterations: three cases contained sequence alterations within intronic regions, three cases with silent mutation (sequence alteration in codon without amino acid alteration), and three cases contained missense mutations (one case each in exons 5, 6 and 9). Immunohistochemical staining demonstrated that two of three cases with missense mutations and one case with an intronic sequence alteration over-expressed p53 protein in tumour cell nuclei. We observed no association between p53 gene mutation and p21/WAF1/Cip-1 expression. The relatively high incidence of p53 gene mutations or intronic sequence alteration in multiple and malignant phaeochromocytomas, but not in benign solitary cases, suggests that p53 mutation could play some role in the pathogenesis of multiple and/or malignant phaeochromocytomas.
